oscillations and an associated contraction in small airway SMCs. The subsequent exposure to an IP 3R antagonist, 2-aminoethoxydiphenyl borate (2-APB), inhibited the Ca 2ϩ oscillations and induced airway relaxation in a concentration-dependent manner. 2-APB also inhibited Ca 2ϩ waves generated by the photolytic release of IP3. However, the RyR antagonist ryanodine had no significant effect, at any concentration, on airway contraction or agonist-or IP 3-induced Ca 2ϩ oscillations or Ca 2ϩ wave propagation. By contrast, a second RyR antagonist, tetracaine, relaxed agonist-contracted airways and inhibited agonist-induced Ca 2ϩ oscillations in a concentration-dependent manner. However, tetracaine did not affect IP 3-induced Ca 2ϩ release or wave propagation nor the Ca 2ϩ content of SMC Ca 2ϩ stores as evaluated by Ca 2ϩ -release induced by caffeine. Conversely, both ryanodine and tetracaine completely blocked agonist-independent slow Ca 2ϩ oscillations induced by KCl. The inhibitory effects of 2-APB and absence of an effect of ryanodine on MCh-induced airway contraction or Ca 2ϩ oscillations of SMCs were also observed at 37°C. In Ca 2ϩ -permeable SMCs, tetracaine inhibited agonist-induced contraction without affecting intracellular Ca 2ϩ levels indicating that relaxation also resulted from a reduction in Ca 2ϩ sensitivity. These results indicate that agonist-induced Ca 2ϩ oscillations in mouse small airway SMCs are primary mediated via IP 3Rs and that tetracaine induces relaxation by both decreasing Ca 2ϩ sensitivity and inhibiting agonist-induced Ca 2ϩ oscillations via an IP3-dependent mechanism.
lung slices; Ca 2ϩ -induced Ca 2ϩ release; membrane depolarization; tetracaine IN AIRWAY smooth muscle cells (SMCs), agonist-induced contraction is associated with an elevation in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ). However, this increase of [Ca 2ϩ ] i is not steady but occurs as repetitive Ca 2ϩ waves propagating along the length of the SMCs (6, 33, 43, 44) . The basic mechanism underlying these Ca 2ϩ oscillations consists of a cyclic Ca 2ϩ release from, and reuptake to, the sarcoplasmic reticulum (SR) via specialized receptor/Ca 2ϩ channels and Ca 2ϩ pumps together with a Ca 2ϩ influx to replace any Ca 2ϩ lost across the cell membrane to the extracellular space (8) .
There are two major types of Ca 2ϩ release channels on the SR of airway SMCs, inositol 1,4,5-trisphosphate (IP 3 ) receptors (IP 3 Rs) and ryanodine receptors (RyRs) (1, 2, 31) . Each type of receptors exists as three different isomers, all of which have been identified in the airway SMCs (19, 24, 31, 55) . Although these receptors differ in structure and molecular weight, their functional activity, to mediate Ca 2ϩ release from the SR, is similar. However, each receptor type is regulated in a different manner. IP 3 Rs are activated by IP 3 (22) , produced from phosphatidylinositol 4,5-bisphosphate (PIP 2 ) by G␣ qactivated PLC␤ in response to G protein-coupled receptor (GPCR) agonists. In addition, the open probability of the IP 3 R is also modulated by [Ca 2ϩ ] i ; increasing [Ca 2ϩ ] i serves to enhance IP 3 R opening, but high [Ca 2ϩ ] i can reduce the open probability of some IP 3 Rs (10, 22, 27) . In contrast to the IP 3 R, the opening of the RyRs is primarily modulated by [Ca 2ϩ ] i . However, SR luminal Ca 2ϩ concentration may also serve to regulate the RyR and IP 3 R (21, 22) . In addition, the second messenger, cyclic ADP-ribose (cADPR), also has been implicated in the activation of RyRs in association with agonistinduced Ca 2ϩ signaling (29) . To explore the regulation of agonist-induced Ca 2ϩ oscillations of SMCs, it is crucial to first understand the mechanisms mediating the cyclic Ca 2ϩ release from SR. Generally, it is acknowledged that the initiation of SMC Ca 2ϩ oscillations is mediated by Ca 2ϩ release from SR via the IP 3 R (7, 9, 37). However, it has been a long-standing debate in airway or other types of SMCs as to whether RyRs are involved and are required to maintain cyclic Ca 2ϩ release and the propagation of Ca 2ϩ waves by Ca 2ϩ -induced Ca 2ϩ release (CICR) (14, 31, 44, 46, 57) or, alternatively, if the entire process was exclusively accomplished by activated IP 3 R without significant RyRs involvement (34, 36, 50) .
The aim of the present research is to determine the relative contribution of the IP 3 Rs and RyRs to agonist-induced intracellular Ca 2ϩ signaling of airway SMCs. Most previous investigations have relied on pharmacological approaches, using RyR inhibitors, such as ryanodine, dantrolene, and tetracaine, and IP 3 R inhibitors, such as xestospongin C (XeC) and 2-aminoethoxydiphenyl borate (2-APB). Unfortunately, all of these drugs have some nonspecific effects that will confound results if the assays are not sufficiently specific (49) . Consequently, to diminish the misinterpretation of experimental data and obtain a consistent mechanism, we have examined the action of these pharmacological agents on the IP 3 sensitivity of the SMCs. Therefore, it appears that tetracaine, although often used as a RyR inhibitor in channel studies, inhibits agonist-induced airway contraction by modulating receptor-G protein interaction to decrease both IP 3 production and Ca 2ϩ sensitivity. From these data, we suggest that in mouse airway SMCs the IP 3 R serves as the primary receptor in the initiation and maintenance of intracellular Ca 2ϩ signaling during agonist-induced airway contraction. An involvement of RyRs is not required in agonist-induced Ca 2ϩ responses in normal physiological conditions. However, it is not known whether the RyR may become involved and change IP 3 Rmediated Ca 2ϩ signaling of airway SMCs in disease conditions such as airway hyperresponsiveness.
MATERIALS AND METHODS

Materials.
Cell culture reagents were obtained from GIBCO-Invitrogen; Oregon Green 488 BAPTA-1 AM was obtained form Molecular Probes-Invitrogen; and caged-iso-Ins(1,4,5)P 3/propionoxymethyl ester (PM) was obtained from Alexis Biochemicals (San Diego, CA) and dissolved in DMSO, aliquoted, and frozen at Ϫ80°C. Other reagents were obtained from Sigma-Aldrich or Calbiochem. Hanks-Balanced Salt Solution (HBSS) was supplemented with 20 mM HEPES buffer (sHBSS) and adjusted to pH 7.4.
Lung slices. The preparation of lung slices has been previously described in detail (43) . Briefly, male BALB/c mice (7-10 wk; Charles River Breeding Laboratories, Needham, MA) were killed by intraperitoneal injection of 0.3 ml of pentobarbital sodium (Nembutal) as approved by the Institutional Animal Care and Use Committee of the University of Massachusetts Medical School. After the thoracic cavity was opened, the lungs were inflated with ϳ1.3-ml warm (37°C) ϳ2% agarose in sHBSS via a catheter cannulated into the trachea. The agarose was followed by a final injection of a bolus of air (ϳ0.2 ml) to flush the agarose out of the airways and into the distal alveoli. After the agarose was gelled with cold sHBSS (ϳ4°C), the lung lobes were removed and sectioned into ϳ140-m thick slices with a vibratome. Slices were maintained in DMEM and antibiotics at 37°C and 10% CO 2 for up to 3 days.
To conduct experiments at 37°C, the perfusion system and microscope were enclosed in a Plexiglas chamber and heated with a custom-built heater consisting of two heater elements (AF20-300-120-1D-K-10-3.1; Farnam Custom Products, Philadelphia, PA) coupled with circulating fans (1976K37; McMaster-Carr Supply, Chicago, IL). The temperature was monitored and regulated by a T thermocouple (HTTC36-T-14G-6; Omega Engineering, Stamford, CT) and a thermal controller (CC-A10; Farnam Custom Products).
Measurement of airway contraction and relaxation. Lung slices were transferred to a large cover glass on a Plexiglas support, and a nylon mesh with a small hole cut in it, to expose the selected airway, was placed over the slice to hold it in position. A second, smaller cover glass, edged with silicone grease, was placed on the top of nylon mesh to form a sealed chamber. Experimental solutions, selected by electronic valves under computer control, were perfused through the chamber under gravity flow. Experiments were performed at either RT or 37°C. Phase-contrast images of airway contraction were collected with an inverted microscope (IX71; Olympus America, Melville, NY) with a ϫ10 objective, a zoom adapter, and a CCD camera (RS-170 video in conjunction with a frame grabber; Picolo; Euresys, Itasca, IL) at 1 frame every 2 s. Images were captured by Video Savant (IO Industries, London, Ontario, Canada), an imageacquisition software package, and stored on a hard drive. Airway contraction was measured by determining the change in lumen area, with respect to the initial lumen area, by pixel summing with custom-written macros (43) .
Measurement of intracellular Ca 2ϩ signaling. Approximately 15 lung slices were placed in 2 ml of sHBSS containing 20 M Oregon Green 488 BAPTA-1 AM, 100 M sulfobromophthalein (an inhibitor of anion exchanges to reduce dye extrusion), and 0.1% Pluronic F-127 and incubated in the dark for 1 h at 30°C. The slices were washed in sHBSS with 100 M sulfobromophthalein for an additional 30 min at 30°C to allow for dye deesterification. The lung slices were placed in the perfusion chamber as described above. The intracellular Ca 2ϩ signaling was examined with either a custom-built video-rate confocal microscope or 2-photon scanning laser microscope as previously described (4, 43) . Fluorescent images were recorded at a rate of 15 or 30 images per second. Fluorescence intensity of the SMCs was determined with respect to time (image number) from the average gray value of user-selected regions of interest (ROI; 6 ϫ 6 pixels) within the cells with custom-written software. Fluorescence intensity was expressed in absolute units or in relative terms as a fluorescence ratio (F/F0) normalized to the initial fluorescent intensity (F0).
Flash photolysis of caged-IP3. Flash photolysis of caged-IP3 was used to experimentally increase the [IP3]i. Lung slices were initially loaded with Oregon Green 488 BAPTA-1 AM as described above and subsequently incubated with 2 M caged-IP3 for 1 h in sHBSS containing 0.1% Pluronic F-127 and 100 M sulfobromophthalein followed by deesterification for 30 min in sHBSS containing 100 M sulfobromophthalein. The details of the flash photolysis setup have also been previously described (2) . Briefly, a UV flash was generated by an electronic shutter from a filtered (330 caged-IP3 nm) mercury arc lamp and focused as point source into the microscope. The intensity of flash was regulated by neutral density filters. The spot size could be adjusted with an iris diaphragm.
Preparation of Ca 2ϩ -permeabilized lung slices. To clamp the [Ca 2ϩ ]i of airway SMCs at a constant level, it is necessary to increase the permeability of the plasma membrane to Ca 2ϩ . Typically, this has been achieved by the application of detergents or toxins. Unfortunately, these agents frequently increase membrane permeability to other cellular constituents. To overcome this problem, we have developed an alternative approach using caffeine and ryanodine to only increase the permeability of cell membrane to Ca 2ϩ ; the use and verification of this method has been previously described in detail (4) . Briefly, lung slices were simultaneously exposed to 20 
RESULTS
Experiments were only performed on intact airways (100-to 200-m diameter, midposition of the respiratory tract; Ref. 5) with an epithelium displaying active ciliary beating and with a lumen free of agarose (Fig. 1A) . We examined the airway responses to two different agonists (MCh and 5-HT) and KCl to avoid the possibility of characterizing mechanisms that were only specific to single agonist. In addition, because experiments have the best chance of detecting changes in behavior if they are performed in the responsive region of the concentration-response curves, we used agonist concentrations (200 nM) that we (2, 6, 43) have previously found to induce nonsaturated responses of airway contraction and SMC Ca 2ϩ signaling. Effect of 2-APB on agonist-induced airway contraction. To explore the role of the IP 3 R in agonist-induced airway contraction, the airway responses to the IP 3 R antagonist 2-APB were examined. When exposed to 200 nM MCh, the airways responded by contracting and reducing their luminal area within 2 min, after which the contractile state stabilized (at 40 -50% of initial luminal area) while MCh was perfused. Removal of MCh resulted in airway relaxation (Fig. 1, A and B) . When the same airways, again contracted with MCh, were exposed to 2-APB, they quickly relaxed; relaxation was fast in the first 2 min but subsequently slow (Fig. 1B) . The airways recontracted when 2-APB was removed. The amount of relaxation induced by 2-APB is expressed as the percentage increase in luminal area normalized to the contracted area induced by MCh. After 10 min, the airways relaxed 28.44 Ϯ 0.83 and 52.33 Ϯ 5.13% in response to 50 and 100 M 2-APB, respectively ( (Fig. 1C) . These results suggest that the activity of the IP 3 R contributes to airway contraction.
Effect of ryanodine and tetracaine on agonist-induced airway contraction.
To similarly explore the role of the RyR in agonist-induced airway contraction, the airway responses to antagonists of the RyR (ryanodine and tetracaine) were examined. After the airways were contracted with 200 nM MCh, the addition of ryanodine, at concentrations ranging from 1 to 50 M, had little effect on the airway contractile response (Fig. 2) . During the course of these experiments, the airway showed a small, steady relaxation rate (ϳ8% over 10 min), but this process was not altered by the addition of increasing concentrations of ryanodine (Fig. 2, A and C) . Similarly, ryanodine (1, 10, or 50 M) had little effect on 5-HT-induced (200 nM) contractile responses (Fig. 2C ). These results suggest that the RyR is not involved in agonist-induced airway contraction.
Surprisingly, in contrast to the effects of ryanodine, tetracaine, an antagonist used in other studies to implicate the RyR in airway contraction, induced a significant relaxation of both MCh-and 5-HT-induced airway contraction. In response to tetracaine, contracted airways quickly relaxed to a plateau level within 3 min in a concentration-dependent manner; a near full relaxation was induced by 50 M tetracaine (Fig. 2, B and D) . This tetracaine effect was readily reversible; the airways quickly recontracted when tetracaine was removed (Fig. 2B) . oscillations stabilized after ϳ2 min of MCh exposure. These changes in the intracellular Ca 2ϩ signaling have been previously shown to closely correlate with the contractile response of the airway SMCs (2, 43) .
Effect of 2-APB on agonist-induced
The subsequent exposure to 2-APB gradually slowed the Ca 2ϩ oscillations (from 20.5 Ϯ 1.8 to 15.8 Ϯ 2.6 min Ϫ1 after oscillations (at 100 M; Fig. 3C ). When 2-APB was removed, the Ca 2ϩ oscillations resumed and gradually increased their frequency to approach the original rate after 3 min. The time course of this inhibition (ϳ2 min) and restoration of the Ca 2ϩ signaling correlates with the time taken for the airways to relax and recontract in response to 2-APB (Fig. 3C) . A similar cessation of 5-HT-induced (200 nM) Ca 2ϩ oscillations by 100 M 2-APB was observed in three different airways from two mice.
Effect of ryanodine and tetracaine on agonist-induced Ca 2ϩ
oscillations. In keeping with the observation that ryanodine had no effect on airway contraction, ryanodine (examined with 1, 10, or 50 M) had no significant effect on the frequency of MCh-induced Ca 2ϩ oscillations ( By contrast, but consistent with its relaxant action, tetracaine at 10 M slowed the frequency of MCh-induced (200 nM) Ca 2ϩ oscillations within 2 min ( Fig. 5A ; from 23.2 Ϯ 3.5 to 14.6 Ϯ 1.0 min Ϫ1 after 5 min of exposure). In addition, the period and waveform of these slowed Ca 2ϩ oscillations also became irregular. Higher concentrations (50 M) of tetracaine stopped the Ca 2ϩ oscillations after 1 min. Airway relaxation was tightly coupled to this cessation of the Ca 2ϩ oscillations (Fig. 5B) . The Ca 2ϩ oscillations were restored to normal on tetracaine removal (n ϭ 4, from different slices from 3 mice). A similar complete inhibitory action of 50 M tetracaine on 5-HT-induced Ca 2ϩ oscillations was observed (data not shown).
Second messenger mediating Ca 2ϩ oscillations. In many cases, Ca 2ϩ oscillations, involving repetitive Ca 2ϩ release and reuptake from the SR, are mediated by agonist-induced production of IP 3 acting on the IP 3 R. A similar process of sensitizing the RyR with the second messenger cADPR can also occur and has been proposed as a regulatory mechanism of agonist-induced Ca 2ϩ oscillations in airway SMCs. Because both the IP 3 R and RyR are implicated in airway SMC Ca 2ϩ signaling, we performed studies to determine the predominant messenger mediating agonist-induced Ca 2ϩ oscillations in mouse airway SMCs.
We examined the effect of the photolytic release of IP 3 (uncaging) on airway SMCs and found that the increase in [IP 3 ] i , following exposure to UV light, induced repetitive Ca 2ϩ waves that propagated from the illuminated area to the rest of the SMC (Fig. 6A) . The frequency and number of these Ca 2ϩ oscillations was increased by an increase in the UV exposure time (Fig. 6B ). These IP 3 -induced Ca 2ϩ oscillations mimicked concentration-dependent agonist-induced Ca 2ϩ oscillations and were accompanied by a contractile response. Because cADPR is not cell-permeable, similar sensitization experiments of the RyR with cADPR were not possible. Consequently, we took the opposite approach and applied the cell-permeable competitive inhibitor of cADPR, 8-bromocADPR (8-Br-cADPR), and examined its effect on MChinduced SMC Ca 2ϩ signaling and airway contraction. No significant changes in the Ca 2ϩ oscillations or contractile responses of the airways were observed during 20-min incubation with 100 M 8-Br-cADPR (data not shown). Collectively, these results with caged-IP 3 and 8-Br-cADPR suggest that IP 3 is the primary intracellular mediator responsible for the generation of Ca 2ϩ oscillations in mouse airway SMCs. 3 -induced Ca 2ϩ release. In view of our earlier result that 2-APB inhibited agonist-induced Ca 2ϩ oscillations (Fig. 3) , we investigated the effect of 2-APB on IP 3 -induced Ca 2ϩ release. It is important to note that in these experiments, the duration of the UV flash used for photolysis was reduced to 0.2 s so that it only induced a single Ca 2ϩ wave within the SMC (Fig. 6B) . This adjustment allowed us to release a small but similar amount of IP 3 multiple times in the same SMC and thereby compare changes in the Ca 2ϩ signaling of the same SMC before and after application of 2-APB.
Effect of 2-APB on IP
Under these conditions, the first UV flash induced a single Ca 2ϩ transient in the SMC (Fig. 7) . However, after 3 min of exposure to 100 M 2-APB, the elevation of [Ca 2ϩ ] i in response to a second photolysis of caged-IP 3 was virtually eliminated, and no Ca 2ϩ wave was observed in SMCs. When the 2-APB was removed, the third UV flash of similar intensity once again induced a transient increase in [Ca 2ϩ ] i and a propagating Ca 2ϩ wave that was indistinguishable from that induced by the first UV flash (Fig. 7, A and C) .
In addition to its action on the IP 3 R, 2-APB also appears to inhibit store-operated Ca 2ϩ entry (SOC) (11) , and this could reduce the amount of Ca 2ϩ stored within the SR. Consequently, to rule out the possibility that emptying of internal Ca 2ϩ stores during the course of experiments was responsible for the abolishment of IP 3 -induced Ca 2ϩ release by 2-APB, we repeated the above experiments in the absence of Ca 2ϩ entry by the removal of extracellular Ca 2ϩ . As shown in Fig. 7 Fig. 8A ) and 50 M tetracaine (Fig. 8B ) had no effect on repetitive flash-induced Ca 2ϩ transients or the ability to propagate Ca 2ϩ waves in SMC. These results also indicated that the RyRs do not contribute to the Ca 2ϩ transients initiated by IP 3 and were consistent with the action of ryanodine on Ca 2ϩ oscillations. In addition, it also implies that the inhibitory effect of tetracaine on agonist-induced Ca 2ϩ oscillations was not mediated by inhibiting Ca 2ϩ release via the IP 3 R. Alternative explanations are that tetracaine leads to the depletion of the internal Ca 2ϩ store (25) or that it decreases the production of IP 3 .
Effect of tetracaine on refilling of the internal Ca 2ϩ store. To investigate the effect of tetracaine on the Ca 2ϩ capacity of SR, we examined the contractile responses and Ca 2ϩ signaling of airway SMCs to repetitive stimuli of caffeine (Fig. 9) . In these experiments, we found that the airway contractile response to 20 mM caffeine was similar before, during, or after exposure of the airways to 50 M tetracaine (Fig. 9A) . A comparable set of results was obtained with respect to the Ca 2ϩ release induced by caffeine (Fig. 9B) stores. The alternative possibility that tetracaine is acting as a RyR antagonist to reduce agonist-induced Ca 2ϩ oscillations also appears unlikely in view of our findings that ryanodine, a well-documented specific antagonist of the RyR, had no effect on agonist-induced Ca 2ϩ oscillations. As a result, we are forced to hypothesize that, in intact SMCs, tetracaine acts via a mechanism other than RyR inhibition even though tetracaine may serve as a RyR antagonist in studies with isolated channels or cell extracts.
Consequently, we hypothesized that tetracaine decreases the amount of IP 3 available to drive the Ca 2ϩ oscillations. To test this idea, we used photolysis to increase the [IP 3 ] i in cells in which the agonist-induced oscillations had been inhibited with tetracaine (Fig. 10) . In response to flash photolysis, the Ca 2ϩ oscillations were reinitiated and lasted for ϳ1 min. This Ca 2ϩ response was associated with a transient recontraction of the SMCs.
Effect of tetracaine on agonist-induced contraction of permeabilized SMCs. The idea that tetracaine acts by another mechanism is further supported by the observation that a greater airway relaxation is induced by tetracaine compared with 2-APB (at low concentrations; Figs. 1B and 2B) . The fact that the Ca 2ϩ oscillations are slowed to a similar extent by tetracaine and 2-APB (Figs. 3B and 5A ) implies that the Ca 2ϩ sensitivity of the airway has been decreased by tetracaine. To investigate this possibility, we examined the responses of lung slices permeabilized to Ca 2ϩ with caffeine and ryanodine. ] i , these permeabilized mouse airways are fully relaxed. This response is fully described in previous work (4) and has been ascribed to a Ca 2ϩ -dependent decrease in Ca 2ϩ sensitivity. Importantly, during the subsequent contractile and relaxant responses induced by agonists or tetracaine, there was no significant change in the intracellular Ca 2ϩ signal in these permeabilized SMCs (Fig. 11, C and D) . When the permeabilized airways were exposed to MCh, they responded with a significant contraction. Because the Ca 2ϩ levels did not change, this contraction is attributed to a MCh-induced increase in Ca 2ϩ sensitization. In the presence of MCh, exposure to tetracaine relaxed the airway in a concentration-dependent manner, from 2.10 Ϯ 0.42% at 1 M tetracaine to 60.78 Ϯ 4.09% at 50 M tetracaine (Fig. 11,  A and B) . This relaxation indicated that tetracaine also acts by reducing airway Ca 2ϩ sensitivity.
Effect of ryanodine and tetracaine on KCl-induced airway contraction and Ca
2ϩ signaling of SMCs. Although ryanodine and tetracaine had no effect on IP 3 oscillations slowed down and stopped after 4 min, whereas the basal level of [Ca 2ϩ ] i gradually increased (Fig. 12A) . Tetracaine also blocked the KCl-induced Ca 2ϩ oscillations, but this stoppage was not accompanied by an elevation of baseline level of Ca 2ϩ (Fig. 12C) . These slow frequency, unsynchronized KCl-induced Ca 2ϩ oscillations resulted in the twitching of individual SMCs and, because of a lack of a coordinated contractile effort, this resulted in a minimal airway contraction (ϳ20% reduction of luminal area). In the presence of either ryanodine or tetracaine, the twitching of individual SMC stopped. However, the airway only relaxed in the presence of tetracaine (Fig. 12, B and D) . These responses are consistent with the observation that ryanodine, but not tetracaine, induced an elevation of basal [Ca 2ϩ ] i after the cessation of the KCl-induced Ca 2ϩ oscillations. In keeping with the irreversible binding of ryanodine to the RyR, twitching of the SMCs did not reoccur on the removal of ryanodine (Fig. 12B) . By contrast, SMC twitching resumed after tetracaine removal, a result indicating a reversible weak binding to the RyR (Fig. 12D ). These results demonstrate the effectiveness of ryanodine and tetracaine in blocking KClinduced Ca 2ϩ signaling.
Influence of temperature on the activity of IP 3 Rs and RyRs.
To rule out the possibility that the insensitivity of the RyR to antagonists is a temperature-dependent effect, we examined the contribution of the IP 3 Rs and RyRs to MCh-induced Ca 2ϩ oscillations and contraction in airway SMCs at 37°C.
In response to 200 nM MCh at 37°C, the extent of airway contraction was similar to that observed at RT ( Fig. 13A;  ϳ45%; Ref. 3 ). This agonist-induced contraction was associated with a similar elevation of [Ca 2ϩ ] i in the form of Ca 2ϩ oscillations (Fig. 14A) . However, the frequency of the Ca 2ϩ oscillations induced by 200 nM MCh at 37°C was much higher (ϳ67 min Ϫ1 ) than that at RT (ϳ20 min Ϫ1 ) (3). These repetitive Ca 2ϩ waves started frequently from one end of the SMC and propagated along the entire cell. The propagating velocity of the waves was 94.6 Ϯ 6.9 m/s (n ϭ 5 different slices from 3 mice), much greater than that at RT (P Ͻ 0.05). The fast Ca 2ϩ oscillations were clearly observed in the presence of MCh and persisted while MCh was present for Ͼ5 min.
When the IP 3 R antagonist 2-APB was added to the MCh (200 nM)-contracted airway SMCs at 37°C, a concentrationdependent relaxation was observed (Fig. 13, A and B) . A relaxation of 19.3 Ϯ 2.1 and 46.8 Ϯ 3.8% was induced by 50 and 100 M 2-APB, respectively, after 10 min. In keeping with this relaxation response, 100 M 2-APB, at 37°C, slowed the fast MCh-induced Ca 2ϩ oscillations of airway SMCs from 69.3 Ϯ 5.2 to 33.5 Ϯ 4.3 min Ϫ1 after 3 min of exposure ( Fig. 14B ; n ϭ 6 different airways from 3 mice). When 2-APB was removed, the frequency of the Ca 2ϩ oscillations gradually increased to the original rate. Although 2-APB reduced both MCh-induced airway contraction and Ca 2ϩ oscillations at 37°C, this inhibitory action was reduced compared with its action at RT (compare Figs. 1 and 3 with Figs. 13 and 14; P Ͻ 0.05 for 50 and 100 M 2-APB). This apparent attenuation of the inhibitory effect of 2-APB most likely results from the relative increase in the frequency of the Ca 2ϩ oscillations at an equal concentration of MCh at 37°C.
When airways contracted with MCh (200 nM) at 37°C were exposed to ryanodine (1, 10, or 50 M), airway contraction was not substantially affected by any concentration of ryanodine (Fig. 13, C and D) . Similarly, 50 M ryanodine did not significantly alter the frequency of MCh-induced Ca 2ϩ oscillations (71.7 Ϯ 6.2 min Ϫ1 ) after 3 min (68.5 Ϯ 5.0 min
Ϫ1
, n ϭ 9 different airways from 4 mice; Fig. 14C ) following the propagation of Ͼ200 Ca 2ϩ waves along the SMCs. This is equivalent to a period of ϳ10 min at RT where the Ca ] i was slowly wave occurring at 82.5 Ϯ 8.0 s after ryanodine exposure (Fig.  14D) , a response similar to that found at RT. This fast action of ryanodine on KCl-induced oscillations indicates that ryanodine interacts quickly with Ca 2ϩ -activated RyRs and, importantly, implies that the much delayed changes in the form of the agonist-induced Ca 2ϩ waves result from an indirect action of ryanodine. The increased baseline of [Ca 2ϩ ] i indicates a Ca 2ϩ leakage and subsequent depletion of Ca 2ϩ from the SR. We suggest the most likely explanation for this is a temperaturedependent increase in the random opening of the RyR that allows ryanodine binding. Therefore, at 37°C, a faster accumulation of RyRs, in an open state can occur to drain the SR of Ca 2ϩ .
DISCUSSION
In this study, we examined the contribution of IP 3 R and RyR to agonist-induced Ca 2ϩ signaling and contraction of airway SMCs. The IP 3 Rs and RyRs appear to be colocalized in SMCs (7, 39) , and, as a result, these receptors may interact during SMC Ca 2ϩ signaling. Consequently, pharmacological agents that selectively block either the IP 3 Rs or RyRs have been frequently used to determine the role of each receptor. However, the interpretation of such experiments requires careful consideration in view of the nonspecific effects of these agents. For example, although ryanodine can increase or decrease the conductance of the RyR in a concentration-dependent manner, this action can also alter the Ca 2ϩ content of the SR (4, 34, 53) . As a result, the impact of ryanodine on Ca 2ϩ signaling may be due to a direct action on the RyR or indirect action on IP 3 R-mediated Ca 2ϩ signals that use the SR Ca 2ϩ store. Similarly, tetracaine, in addition to inhibiting RyR, acts as a local anesthetic and has been reported to block N-methyl-D-aspartate receptors (41) and K ϩ channels (32) . Likewise, in addition to acting as a cell-permeant IP 3 R antagonist, 2-APB may also inhibit SOC and SERCA activity, which has the result of increasing Ca 2ϩ leakage from the SR (40, 42) . In addition to nonspecific effects associated with the IP 3 R antagonist XeC (16, 48) , another difficulty associated with XeC is its low solubility. In previous studies, we (6) reported that the prior prolonged incubation of lung slices with XeC prevented agonist-induced Ca 2ϩ signaling. However, in our short-term perfusion experiments reported here with the maximal possible concentration of XeC (20 M), we did not observe an inhibition of MCh-induced airway contraction (data not shown). This suggests that low concentrations of antagonist are insufficient to immediately compete with high local concentration of agonist-generated IP 3 . Because experiments with a long-term exposure to XeC are more susceptible to nonspecific effects, we believe short-term responses are likely to be more reliable. Heparin, another commonly used IP 3 R antagonist, has the disadvantages of membrane impermeability, an action on RyRs and the ability to uncouple G protein signaling pathways (15, 20, 49) . Although there is clearly no exclusive experimental drug or method, if we are going to understand airway hyperresponsiveness and how it develops in asthma, it is imperative that we understand the contribution of IP 3 Rs and RyRs to airway contraction. Consequently, we have carefully examined the effects of inhibiting IP 3 Rs and RyRs in response to a variety of different stimuli, including agonists, caged-IP 3 , and membrane depolarization, to control for the nonspecific effects of these receptor antagonists.
We and others have shown that airway SMC contraction, induced by agonists, is mediated via Ca 2ϩ oscillations (29, 47) . Consequently, we initially examined the effect of IP 3 R or RyR antagonists on these two basic responses. When 2-APB was applied to airways contracted with agonist, the airways displayed a concentration-dependent relaxation. This relaxation was associated with a slowing or near cessation of the Ca 2ϩ oscillations. It was also noticed that the airway was not completely relaxed when a high concentration of 2-APB was applied and the intracellular Ca 2ϩ signaling was significantly diminished. This phenomenon can be interpreted by the high Ca 2ϩ sensitivity in the presence of agonist. Because 2-APB had no effect on Ca 2ϩ sensitization, the airway could maintain a significant contraction with a small elevation of [Ca 2ϩ ] i . This relaxant effect is different to that of ␤ 2 -agonists that inhibit both Ca 2ϩ signaling and Ca 2ϩ sensitivity. By contrast, the addition of ryanodine to agonist-contracted airways had no effect on either their contractile state or the frequency of the Ca 2ϩ oscillations in their SMCs. We anticipated that the velocity of the Ca 2ϩ waves would either slow or break up into discrete Ca 2ϩ domains (i.e., Ca 2ϩ puffs) if a contribution by the RyRs was inhibited. However, the velocity or form of the propagating Ca 2ϩ waves associated with the Ca 2ϩ oscillations was unaffected by ryanodine. These results strongly indicate that the IP 3 Rs primarily contribute to the generation and propagation of agonist-induced Ca 2ϩ oscillations. This conclusion is consistent with the finding that the number of IP 3 Rs exceeds that of RyRs by 10-fold in SMCs (54) . In addition, under physiological conditions, [Ca 2ϩ ] i only has to increase by submicromolar concentrations (Ͻ1 M) to activate the IP 3 R in the presence of IP 3 (30) . By contrast, RyRs often require ) and sustained Ca 2ϩ oscillations. After the MCh-induced Ca 2ϩ oscillations had stabilized (ϳ3 min), 2-APB or ryanodine was added to the lung slice. The Ca 2ϩ oscillations were inhibited by 2-APB (B) but unaffected by ryanodine (C) after 3 min. Representative data are from Ն6 slices from 3 mice for each antagonist. In contrast, Ca 2ϩ oscillations induced by KCl (50 mM) were rapidly stopped by 50 M ryanodine (D), and this was associated with an increase in baseline Ca 2ϩ . Representative data are from Ն5 different airways from 3 mice.
[Ca 2ϩ ] i increases up to 15 M for activation (12, 21) . Therefore, the propagation of Ca 2ϩ waves by CICR via sensitized IP 3 Rs is likely to occur at lower thresholds of Ca 2ϩ . We recognize that the noninvolvement of the RyR in agonist-induced Ca 2ϩ signaling is in contrast to current ideas forwarded by other investigators from studies with airway SMCs from mouse bronchi (19) , rabbit trachea (28), porcine trachea (14, 31, 44, 45) , and canine (23) or human bronchi (13) . Although it is appealing to attribute this variation to fundamental differences in SMCs between species or even between different airway generations, the more likely scenario is, unfortunately, the misleading, nonspecific effects of the pharmacological agents used to obtain the experimental results. To resolve this conundrum, our aim here has been to address, in detail, the known nonspecific effects of the antagonists and the implications that they raise for Ca 2ϩ signaling in SMCs. The first important response is the inhibition of the IP 3 R with 2-APB. The inhibition of Ca 2ϩ oscillations by 2-APB, supported by the observations with flash photolysis that 2-APB inhibited IP 3 -induced Ca 2ϩ release, is strong evidence for the expected action of 2-APB on the IP 3 R. However, 2-APB has been reported to significantly inhibit SOC (11, 42) and thereby the replenishment of Ca 2ϩ stores. We investigated this idea and found some effect of 2-APB on Ca 2ϩ stores, as judged by caffeine-induced Ca 2ϩ release. Therefore, to ensure that the slowing of the Ca 2ϩ oscillations or the failure of IP 3 to evoke a Ca 2ϩ transient was not the result of store depletion, we examined the ability of IP 3 to release Ca 2ϩ from the SR under conditions that would mimic the full abolishment of SOC, i.e., zero extracellular Ca 2ϩ . In the absence of extracellular Ca 2ϩ , for an equal amount of time as 2-APB exposure, the photolytic release of IP 3 elicited a similar Ca 2ϩ response, confirming that SOC inhibition was not a concern. Similarly, we considered the action of 2-APB on the depletion of the Ca 2ϩ store via an inhibition of SERCA activity and ruled out this possibility by demonstrating that the Ca 2ϩ store was sufficiently replenished to maintain a caffeine-induced Ca 2ϩ response in presence of 2-APB. In addition, compared with our previous studies, 2-APB inhibited the Ca 2ϩ oscillations more quickly than by Ca 2ϩ -store depletion induced by zero extracellular Ca 2ϩ . Consequently, these experiments collectively confirm the primary function of 2-APB as an IP 3 oscillations. An alternative mechanism for the activation of RyRs in airway SMCs is an agonist-stimulated increase in cADPR. Acting as a functional equivalent of IP 3 for IP 3 R, cADPR generated from ␤-NAD by ADP-ribosyl cyclase located as a cell surface receptor (CD38) is believed to facilitate the activation of RyRs via FK506-binding protein 12.6 (FKBP12.6) (17, 18, 45, 52) . The cADPR/CD38 pathway of Ca 2ϩ release is thought to be recruited by receptor-coupled G proteins (29) , but the details are largely unknown. Although the poor membrane permeability of cADPR precluded its direct use in this study, a membrane-permeable competitive inhibitor of cADPR (8-Br-cADPR) had no effect on the MCh-or 5-HT-induced contractile responses or Ca 2ϩ signaling of mouse airway SMCs in lung slices. Therefore, the contribution of cADPR-RyR pathway to agonist-induced Ca 2ϩ oscillations under normal physiological conditions appears to be minimal in mouse airway SMCs.
Another means to activate RyRs is overloading the internal Ca 2ϩ stores (21, 35) . This condition can be experimentally induced by KCl-mediated membrane depolarization to stimulate Ca 2ϩ influx via voltage-dependent Ca 2ϩ channels. The consequence of a cyclic Ca 2ϩ store overload coupled to RyR activation and store emptying was slow frequency Ca 2ϩ oscillations (43) . As might be expected, ryanodine abolished these KCl-induced slow Ca 2ϩ oscillations of airway SMCs by blocking the activated RyR. It also increased the baseline [Ca 2ϩ ] i by eliciting additional Ca 2ϩ leakage from SR via the open RyRs. The importance of this result is that it indicates that the inhibitory effects of ryanodine can be observed in lung slices and that the lack of a response to ryanodine in experiments with agonists is not the result of drug impotency. The positive inhibitory effect of ryanodine is also confirmed by its joint action with caffeine in inhibiting the RyR in the open state.
In addition to demonstrating that IP 3 R is the major contributor to Ca 2ϩ oscillations in mouse airway SMCs, our data also indicate that agonist-induced Ca 2ϩ oscillations are qualitatively similar at RT and 37°C. Only the speed of the Ca 2ϩ oscillations increased, suggesting the fundamental mechanisms underlying the Ca 2ϩ oscillations are not altered by tempera-ture, although it is likely that the kinetics of the process are changed. As a result, the immediate effects of ryanodine or 2-APB on agonist-induced Ca 2ϩ oscillations were similar at RT and 37°C. This behavior is in contrast to vascular SMCs in which agonist-induced Ca 2ϩ oscillations occurred at RT but changed to a uniform increase in [Ca 2ϩ ] i at higher temperature (32°C) in association with the development of myogenic tone in SMCs (56) . The higher [Ca 2ϩ ] i was believed to inactivate the IP 3 R.
A surprising finding in our study was the inhibitory effects of tetracaine on agonist-induced Ca 2ϩ signaling. The conventional inhibitor effect of tetracaine on RyRs was confirmed in airway SMCs by the cessation of KCl-induced Ca 2ϩ oscillations, although this action was relatively weak because it could be reversed with high concentrations of caffeine. More importantly, tetracaine appeared to mediate its action by altering Ca 2ϩ signaling and Ca 2ϩ sensitization. In other studies, tetracaine has been suggested to block IP 3 -mediated Ca 2ϩ release at high concentrations (1 mM) (36, 51) . However, we found that 50 M tetracaine does not affect Ca 2ϩ release in response to IP 3 . Therefore, we suggest the cessation of agonist-induced Ca 2ϩ oscillations in presence of tetracaine results from an absence of IP 3 . This idea is supported by the reinitiation of Ca 2ϩ oscillations when IP 3 was made available by flash photolysis. Another nonspecific effect of tetracaine is inhibition of membrane ion channels and Ca 2ϩ influx, but this appears to be minimal in airway SMCs because repetitive exposures to caffeine in the presence of tetracaine induced similar contractile and Ca 2ϩ responses and had no effect on the [Ca 2ϩ ] i of permeabilized SMCs. Consequently, we propose that tetracaine acts at the membrane level to inhibit the receptor-coupled dual pathways that regulate the activation of PLC␤ for IP 3 production and G protein-coupled activation of Rho kinase to modulate Ca 2ϩ sensitization. Similar actions of tetracaine have been reported previously (26) to explain how tetracaine may act as a local anesthetic. Collectively, these results indicated that tetracaine, and other similar local anesthetic agents, such as procaine, inhibit the Ca 2ϩ responses of mouse airway SMCs in a manner unrelated to the RyRs. More importantly, these conclusions emphasize that caution is required when explaining the effects of tetracaine on airway SMC physiology of other species. In conclusion, our experiments demonstrate that the IP 3 R plays the major role in GPCR agonist-induced Ca 2ϩ oscillations and that RyR-mediated CICR does not appear to be involved in normal physiological conditions.
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